ArticleHypertension research : official journal of the Japanese Society of Hypertension2025
Visit-to-visit blood pressure variability and clinical outcomes in peritoneal dialysis - based on machine learning algorithms.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Time-updated explainable machine learning predicts short-term mortality in peritoneal dialysis patients.Renal failure · 2026Article
- From assistant to collaborator: A systematic review of the evolution of artificial intelligence in end-stage renal disease care and management.PLOS digital health · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the association between visit-to-visit blood pressure variability (VVV) in early stage of continuous ambulatory peritoneal dialysis (CAPD) and long-term clinical outcomes, utilizing machine learning algorithms. Patients who initiated CAPD therapy between January 1, 2006, and December 31, 2009 were enrolled. VVV parameters were collected during the first six months of CAPD therapy. Patient follow-up extended to December 31, 2021, for up to 15.8 years. The primary outcome was the occurrence of a three-point major adverse cardiovascular event (MACE). Four machine learning algorithms and competing risk regression analysis were applied to construct predictive models. A total of 666 participants were included in the analysis with a mean age of 47.9 years. One of the six VVV parameters, standard deviation of diastolic blood pressure (SDDBP), was finally enrolled into the MACE predicting model and mortality predicting model. In the MACE predicting model, higher SDDBP was associated with 99% higher MACE risk. The association between SDDBP and MACE risk was attenuated by better residual renal function (p for interaction <0.001). In the mortality predicting model, higher SDDBP was associated with 46% higher mortality risk. This cohort study discerned that high SDDBP in early stage of CAPD indicated increased long-term MACE and mortality risks.
Indexed as
Identifiers
39984751What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.